• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测高甲基化基因作为 HIV 感染者宫颈癌筛查的标志物。

Detection of hypermethylated genes as markers for cervical screening in women living with HIV.

机构信息

Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.

DOI:10.1002/jia2.25165
PMID:30101434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6088247/
Abstract

INTRODUCTION

To evaluate the performance of hypermethylation analysis of ASCL1, LHX8 and ST6GALNAC5 in physician-taken cervical scrapes for detection of cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 in women living with HIV (WLHIV) in South Africa.

METHODS

Samples from a prospective observational cohort study were used for these analyses. Two cohorts were included: a cohort of WLHIV who were invited for cervical screening (n = 321) and a gynaecologic outpatient cohort of women referred for evaluation of abnormal cytology or biopsy proven cervical cancer (n = 108, 60% HIV seropositive). Cervical scrapes collected from all subjects were analysed for hypermethylation of ASCL1, LHX8 and ST6GALNAC5 by multiplex quantitative methylation specific PCR (qMSP). Histology endpoints were available for all study subjects.

RESULTS

Hypermethylation levels of ASCL1, LHX8 and ST6GALNAC5 increased with severity of cervical disease. The performance for detection of CIN3 or worse (CIN3 ) as assessed by the area under the receiver operating characteristic (ROC) curves (AUC) was good for ASCL1 and LHX8 (AUC 0.79 and 0.81 respectively), and moderate for ST6GALNAC5 (AUC 0.71). At a threshold corresponding to 75% specificity, CIN3 sensitivity was 72.1% for ASCL1 and 73.8% for LHX8 and all samples from women with cervical cancer scored positive for these two markers.

CONCLUSIONS

Hypermethylation analysis of ASCL1 or LHX8 in cervical scrape material of WLHIV detects all cervical carcinomas with an acceptable sensitivity and good specificity for CIN3 , warranting further exploration of these methylation markers as a stand-alone test for cervical screening in low-resource settings.

摘要

简介

评估 ASCL1、LHX8 和 ST6GALNAC5 的超甲基化分析在南非 HIV 感染者(WLHIV)的医生采集宫颈刮片中对宫颈癌和宫颈上皮内瘤变(CIN)3 级的检测性能。

方法

这些分析使用前瞻性观察队列研究的样本。包括两个队列:邀请进行宫颈筛查的 WLHIV 队列(n=321)和因异常细胞学或活检证实宫颈癌而就诊的妇科门诊队列(n=108,60% HIV 血清阳性)。所有受试者的宫颈刮片均采用多重定量甲基化特异性 PCR(qMSP)分析 ASCL1、LHX8 和 ST6GALNAC5 的超甲基化。所有研究对象均有组织学终点。

结果

ASCL1、LHX8 和 ST6GALNAC5 的超甲基化水平随宫颈疾病严重程度的增加而增加。根据受试者工作特征(ROC)曲线下面积(AUC)评估,ASCL1 和 LHX8 对 CIN3 或更高级别病变(CIN3+)的检测性能良好(AUC 分别为 0.79 和 0.81),而 ST6GALNAC5 的检测性能为中度(AUC 为 0.71)。在对应于 75%特异性的阈值下,ASCL1 的 CIN3 灵敏度为 72.1%,LHX8 的灵敏度为 73.8%,所有宫颈癌患者的样本均为这两种标志物阳性。

结论

ASCL1 或 LHX8 在 WLHIV 宫颈刮片材料中的超甲基化分析可检测到所有宫颈癌,对 CIN3 的敏感性和特异性均可接受,这表明这些甲基化标志物作为一种在资源有限环境下的独立宫颈癌筛查方法值得进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/8618bff040e6/JIA2-21-e25165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/a66193479734/JIA2-21-e25165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/1aec13346b45/JIA2-21-e25165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/d0ce64722f86/JIA2-21-e25165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/64fca3bb1d22/JIA2-21-e25165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/8618bff040e6/JIA2-21-e25165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/a66193479734/JIA2-21-e25165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/1aec13346b45/JIA2-21-e25165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/d0ce64722f86/JIA2-21-e25165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/64fca3bb1d22/JIA2-21-e25165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d09/6088247/8618bff040e6/JIA2-21-e25165-g005.jpg

相似文献

1
Detection of hypermethylated genes as markers for cervical screening in women living with HIV.检测高甲基化基因作为 HIV 感染者宫颈癌筛查的标志物。
J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.
2
Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.ASCL1、LHX8、ST6GALNAC5、GHSR、ZIC1 和 SST 的 DNA 甲基化分析在 HPV 阳性女性分流中的表现:来自荷兰基于 HPV 的初级筛查队列的结果。
Int J Cancer. 2022 Feb 1;150(3):440-449. doi: 10.1002/ijc.33820. Epub 2021 Oct 13.
3
HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.HPV16 相关的宫颈癌及癌前病变患者的宿主细胞 DNA 甲基化水平升高。
Int J Mol Sci. 2018 Oct 23;19(11):3297. doi: 10.3390/ijms19113297.
4
Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.ASCL1 和 LHX8 甲基化分析作为南非人类免疫缺陷病毒感染妇女原发性宫颈癌筛查策略的验证。
Clin Infect Dis. 2023 Feb 8;76(3):416-423. doi: 10.1093/cid/ciac801.
5
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.对接受人乳头瘤病毒治疗的 2/3 级宫颈上皮内瘤变的女性进行 ASCL1/LHX8 甲基化分析的治疗后监测。
AIDS. 2022 Jun 1;36(7):953-961. doi: 10.1097/QAD.0000000000003197. Epub 2022 Feb 15.
6
Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.评估从全基因组筛选中获得的六个甲基化标记物,用于检测宫颈癌前病变和癌症。
Epigenomics. 2020 Sep;12(18):1569-1578. doi: 10.2217/epi-2019-0331. Epub 2020 Sep 17.
7
Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.基于人群的宫颈癌筛查项目中,HPV 阳性自我采样的 CIN3+检测中,甲基化panel 作为一种替代分流方法的鉴定。
Clin Epigenetics. 2023 Jun 15;15(1):103. doi: 10.1186/s13148-023-01517-6.
8
Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening Program.基于人群的宫颈癌筛查项目中高危型人乳头瘤病毒阳性自我采样的甲基化分析检测 CIN3+。
Mod Pathol. 2024 Aug;37(8):100528. doi: 10.1016/j.modpat.2024.100528. Epub 2024 May 27.
9
The use of molecular markers for cervical screening of women living with HIV in South Africa.南非使用分子标志物对 HIV 感染者进行宫颈癌筛查。
AIDS. 2019 Nov 1;33(13):2035-2042. doi: 10.1097/QAD.0000000000002325.
10
Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.用于检测复发性宫颈上皮内瘤变的甲基化检测
Int J Cancer. 2023 Dec 15;153(12):2011-2018. doi: 10.1002/ijc.34678. Epub 2023 Aug 4.

引用本文的文献

1
Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A review.宿主细胞DNA甲基化标志物在宫颈筛查及宫颈上皮内瘤变管理中的临床应用:综述
Tumour Virus Res. 2024 Dec 16;19:200308. doi: 10.1016/j.tvr.2024.200308.
2
Advances in cervical cancer: current insights and future directions.宫颈癌的进展:当前见解与未来方向
Cancer Commun (Lond). 2025 Feb;45(2):77-109. doi: 10.1002/cac2.12629. Epub 2024 Nov 29.
3
Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer.

本文引用的文献

1
Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.基于 HPV 的自我采样宫颈癌筛查中 3 个基因甲基化分类器的鉴定和验证。
Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.
2
The effect of ART on cervical cancer precursor lesions.抗逆转录病毒治疗(ART)对宫颈癌前病变的影响。
Lancet HIV. 2018 Jan;5(1):e6-e8. doi: 10.1016/S2352-3018(17)30189-3. Epub 2017 Oct 26.
3
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
针对人乳头瘤病毒(HPV)进行宫颈癌的预防、诊断和治疗。
J Mol Cell Biol. 2025 May 2;16(10). doi: 10.1093/jmcb/mjae046.
4
Methylation-mediated silencing of promotes cervical cancer proliferation, migration and invasion.甲基化介导的[具体基因或分子名称缺失]沉默促进宫颈癌的增殖、迁移和侵袭。
Front Oncol. 2023 Feb 3;13:1010132. doi: 10.3389/fonc.2023.1010132. eCollection 2023.
5
Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.ASCL1 和 LHX8 甲基化分析作为南非人类免疫缺陷病毒感染妇女原发性宫颈癌筛查策略的验证。
Clin Infect Dis. 2023 Feb 8;76(3):416-423. doi: 10.1093/cid/ciac801.
6
Deciphering DNA Methylation in HIV Infection.解析 HIV 感染中的 DNA 甲基化。
Front Immunol. 2021 Dec 2;12:795121. doi: 10.3389/fimmu.2021.795121. eCollection 2021.
7
Epigenetic approaches for cervical neoplasia screening (Review).用于宫颈癌前病变筛查的表观遗传学方法(综述)
Exp Ther Med. 2021 Dec;22(6):1481. doi: 10.3892/etm.2021.10916. Epub 2021 Oct 25.
8
DNA methylation markers have universal prognostic value for anal cancer risk in HIV-negative and HIV-positive individuals.DNA 甲基化标志物对 HIV 阴性和 HIV 阳性个体的肛门癌风险具有普遍的预后价值。
Mol Oncol. 2021 Nov;15(11):3024-3036. doi: 10.1002/1878-0261.12926. Epub 2021 Mar 16.
9
The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.利用宿主细胞 DNA 甲基化分析检测和管理高级别宫颈上皮内瘤变女性:综述。
BJOG. 2021 Feb;128(3):504-514. doi: 10.1111/1471-0528.16395. Epub 2020 Aug 9.
10
DNA methylation for cervical cancer screening: a training set in China.用于宫颈癌筛查的 DNA 甲基化:中国的一个训练集。
Clin Epigenetics. 2020 Jun 23;12(1):91. doi: 10.1186/s13148-020-00885-7.
抗逆转录病毒疗法与人类免疫缺陷病毒感染者的高危型人乳头瘤病毒、宫颈上皮内瘤变和浸润性宫颈癌的关系:系统评价和荟萃分析。
Lancet HIV. 2018 Jan;5(1):e45-e58. doi: 10.1016/S2352-3018(17)30149-2. Epub 2017 Oct 26.
4
Selection of women at risk for cervical cancer in an HIV-infected South African population.在南非 HIV 感染人群中选择宫颈癌高危女性。
AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583.
5
Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.全基因组 DNA 甲基化分析揭示了与 3q 增益相关的甲基化标记物,可用于检测宫颈癌前病变和癌症。
Clin Cancer Res. 2017 Jul 15;23(14):3813-3822. doi: 10.1158/1078-0432.CCR-16-2641. Epub 2017 Jan 24.
6
Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer.在巴西国立癌症研究所接受治疗的感染HIV和未感染HIV的女性宫颈癌患者的治疗结果。
AIDS. 2017 Feb 20;31(4):523-531. doi: 10.1097/QAD.0000000000001367.
7
Secondary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline Summary.子宫颈癌的二级预防:美国临床肿瘤学会资源分层临床实践指南摘要
J Oncol Pract. 2017 Feb;13(2):129-133. doi: 10.1200/JOP.2016.017889. Epub 2016 Nov 15.
8
HIV Infection and Survival Among Women With Cervical Cancer.宫颈癌女性中的HIV感染与生存情况
J Clin Oncol. 2016 Nov 1;34(31):3749-3757. doi: 10.1200/JCO.2016.67.9613.
9
Management of high-risk HPV-positive women for detection of cervical (pre)cancer.高危型 HPV 阳性妇女的宫颈癌(前)病变检测管理。
Expert Rev Mol Diagn. 2016 Sep;16(9):961-74. doi: 10.1080/14737159.2016.1217157. Epub 2016 Aug 5.
10
Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.careHPV在布基纳法索和南非的HIV-1感染女性中检测高级别宫颈上皮内瘤变的性能:HARP研究
Br J Cancer. 2016 Aug 9;115(4):425-30. doi: 10.1038/bjc.2016.207. Epub 2016 Jul 19.